Geoffrey Siwo

Geoffrey Siwo is a Research Assistant Professor in the Department of Learning Health Sciences at the University of Michigan Medical School, and a Research Associate at the Center for Global Health Equity. His research integrates computational approaches like AI and systems biology with fundamental biology to advance equitable drug discovery and clinical medicine. Previously, he held roles at the University of Notre Dame, IBM Research Africa, and the IBM TJ Watson Research Center. He has founded companies including Anza Biotechnologies and Helix Nanotechnologies, and advises organizations like Saguaro Capital Management and Immusoft Corporation.

Education:

• PhD, University of Notre Dame (2014)
• Postdoctoral Fellow, University of Pennsylvania (2015)
• Research Associate, Dartmouth College (2015)
• BSc, Egerton University (2005)

Research Interests: Dr. Siwo focuses on leveraging AI and systems biology to address global health challenges, including drug discovery for infectious diseases like malaria, cancer diagnostics in sub-Saharan Africa, and understanding vaccine hesitancy in low- and middle-income countries. His work emphasizes equity in healthcare access and outcomes.

Affiliations:

• Institute for Healthcare Policy and Innovation
• Center for Global Health Equity
• Precision Health Initiative
• e-Health and Artificial Intelligence Initiative

Grants & Projects: His research spans AI-driven disease modeling, genomic data harmonization, and crowdsourcing innovation in global health. Recent projects include predictive analytics for hepatitis B progression and colorectal cancer early detection.

Labs/Teams: Collaborates across multidisciplinary teams at Michigan Medicine and global health networks, focusing on translational AI solutions for healthcare equity.